Spain Epidemiology Forecast

$ 13.650,00

Spain Epidemiology Forecast

More than 13 million people were diagnosed with cancer across the world in 2010, around 35% of this patient are located in the G7 mature markets (the USA, Japan, France, Germany, Italy, Spain, the UK). Year after year the cancer incidence and mortality is increased in Spain.

  • Countries concerned :

Add to my wishlist

Scope: Hoffmann-Krueger epidemiologists had concentrated 15 types of cancer in Spain

A major strength of this analysis is that the forecast methodology was consistent across the 15 cancers, we used our expertise to give you the most accurate epidemiology forecast for :

 

Breast cancer

Breast cancer HER 2 positive

Breast cancer HER 2 negative

Cervical cancer

Colorectal cancer

Endometrial cancer

Esophageal cancer

Gastric cancer

HCC cancer

HNC  cancer

HNC Laryn

HNC OC Pharyn

Lung NSCLC

Lung SCL cancer

Melanoma cancer

Ovarian cancer

Pancreatic cancer

Prostate cancer

Renal cell carcinoma (RCC)

Sarcoma

Urinary Bladder

 

10-year patient population forecast + 5 years of historical data

 

Key Users:  Oncology Market Research - New Product Planning - Business Development & Licensing

Oncology Market Access – Oncology Marketing leaders

 

Insight: Insight into the cancer strategy in Spain and business development activities

Transparent forecasts methodology and assumptions

Concise and comparable analysis

 

Key epidemiology assumptions are included to give accurate sizing of patient population, epidemiology forecast, key drivers of patient shares.

 

The oncology drug market is one of the fastest-growing markets in the pharmaceutical industry. The treatment of cancer has shifted away from mass market blockbuster drugs toward a more focused attack on the disease with targeted therapies.

 

 

 

Reasons To Buy

 

Hoffmann-Krueger ECF (Epidemiology Cancer Forecast) rich data set and easy-to-use tool allow you to focus on cancer subpopulation segment of interest. Hoffmann-Krueger  ECF (Epidemiology Cancer Forecast) giving the opportunity to use epidemiological projections of key oncology patient population.

  • Country : Spain
  • Cancer Type : HCC | Ovarian Cancer | Esophageal | Lung SCL | Colorectal Cancer | HNC OC Pharyn | Breast cancer HER 2 positive | Renal cell carcinoma (RCC) Sarcoma | HNC | Breast cancer | Pancreatic | Gastric | Melanoma | Endometrial | Lung NSCLC | Cervical Cancer | Urinary Bladder | HNC Laryn | Breast cancer HER 2 negative | Prostate C
  • File : xls